Jordan D Berlin Selected Research

ascrinvacumab

1/2016

A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jordan D Berlin Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 11/2002
17	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2002
14	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 08/2002
7	Nausea 01/2022 - 02/2012
6	Fatigue 01/2022 - 08/2008
5	Neutropenia 01/2020 - 01/2004
4	Adenocarcinoma 01/2014 - 01/2005
3	Vomiting 01/2022 - 04/2013
3	Diarrhea 01/2022 - 02/2012
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 10/2004
3	Neoplasm Metastasis (Metastasis) 10/2018 - 02/2013
2	Fever (Fevers) 01/2022 - 08/2008
2	Microsatellite Instability 01/2018 - 09/2013
2	Hypersensitivity (Allergy) 07/2012 - 08/2007
1	Anemia 01/2022
1	Edema (Dropsy) 01/2022
1	Exanthema (Rash) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Aseptic Meningitis 01/2022
1	Cytopenia 01/2019
1	Dehydration (Water Stress) 01/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Disease Progression 08/2014
1	Clinical Deterioration 06/2014
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2013
1	Fatty Liver 02/2013
1	Stroke (Strokes) 07/2012
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

11	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2002
9	Gemcitabine FDA Link 01/2018 - 08/2002
9	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 08/2002
6	Cetuximab (Erbitux)FDA Link 01/2018 - 10/2004
5	Leucovorin (Folinic Acid)FDA Link 01/2014 - 08/2002
5	ErbB Receptors (EGF Receptor)IBA 01/2012 - 10/2004
4	Monoclonal AntibodiesIBA 01/2017 - 04/2013
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 06/2003
3	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2017
2	veliparibIBA 08/2019 - 01/2019
2	MLN 8237IBA 01/2019 - 12/2018
2	Aurora Kinase AIBA 01/2019 - 12/2018
2	Cytotoxins (Cytolysins)IBA 01/2018 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2004
2	Capecitabine (Xeloda)FDA Link 01/2016 - 02/2012
2	KRN-330IBA 08/2014 - 04/2013
2	Thymidylate SynthaseIBA 01/2014 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2011 - 01/2004
2	LigandsIBA 02/2005 - 10/2004
1	ribociclibIBA 01/2022
1	epacadostatIBA 01/2022
1	parsaclisibIBA 01/2022
1	itacitinibIBA 01/2022
1	binimetinibIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	trifluridine tipiracil drug combinationIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	larotrectinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	ibrutinibIBA 01/2019
1	PlatinumIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	durvalumabIBA 01/2019
1	1- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamideIBA 10/2018
1	STA 9090IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 10/2017
1	Carcinoembryonic AntigenIBA 10/2017
1	Cell Adhesion MoleculesIBA 10/2017
1	labetuzumab govitecanIBA 10/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	linifanibIBA 01/2017
1	cobimetinibIBA 01/2017
1	LY3022859IBA 01/2017
1	ascrinvacumabIBA 01/2016
1	Vorinostat FDA Link 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	Activin Receptors (Activin Receptor)IBA 01/2016
1	Amylases FDA Link 01/2016
1	Differentiation AntigensIBA 08/2014
1	130-nm albumin-bound paclitaxelIBA 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	folfirinoxIBA 01/2014
1	ParaffinIBA 09/2013
1	Glycoproteins (Glycoprotein)IBA 04/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011

Therapy/Procedure

21	Therapeutics 01/2019 - 08/2002
8	Drug Therapy (Chemotherapy) 01/2018 - 05/2003
3	Neoadjuvant Therapy 08/2013 - 05/2007
1	Immunotherapy 01/2016
1	Pancreatectomy 08/2013
1	Hepatectomy 02/2013
1	Biological Therapy 02/2013